These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 34047938)

  • 1. Incidence of thrombotic complications in COVID-19 : On behalf of ICODE: The International COVID-19 Thrombosis Biomarkers Colloquium.
    Jenner WJ; Gorog DA
    J Thromb Thrombolysis; 2021 Nov; 52(4):999-1006. PubMed ID: 34047938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombotic complications in 2928 patients with COVID-19 treated in intensive care: a systematic review.
    Jenner WJ; Kanji R; Mirsadraee S; Gue YX; Price S; Prasad S; Gorog DA
    J Thromb Thrombolysis; 2021 Apr; 51(3):595-607. PubMed ID: 33586113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of protocol-based high-intensity pharmacological thromboprophylaxis on thrombotic events in critically ill COVID-19 patients.
    Atallah B; Sadik ZG; Salem N; El Nekidy WS; Almahmeed W; Park WM; Cherfan A; Hamed F; Mallat J
    Anaesthesia; 2021 Mar; 76(3):327-335. PubMed ID: 33047335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombotic events in critically ill children with coronavirus disease 2019 or multisystem inflammatory syndrome in children.
    Dain AS; Raffini L; Whitworth H
    Curr Opin Pediatr; 2022 Jun; 34(3):261-267. PubMed ID: 35634699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for venous thromboembolism in patients with COVID-19.
    Vandenbriele C; Gorog DA
    J Thromb Thrombolysis; 2021 Nov; 52(4):985-991. PubMed ID: 34019231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombosis in COVID-19: A Narrative Review of Current Literature and Inpatient Management.
    Hsu A; Ohnigian S; Chang A; Liu Y; Zayac AS; Olszewski AJ; Reagan JL
    R I Med J (2013); 2021 Jun; 104(5):14-19. PubMed ID: 34044431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of Anticoagulants in COVID-19: A Review.
    Ngu S; Smith JK; Goldin M
    Am J Ther; 2022 Jul; 29(4):e425-e436. PubMed ID: 35476050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review of venous thromboembolism in COVID-19: A clinical perspective.
    Ozsu S; Gunay E; Konstantinides SV
    Clin Respir J; 2021 May; 15(5):506-512. PubMed ID: 33484090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of thrombotic complications in hospitalised and non-hospitalised patients after COVID-19 diagnosis.
    Tholin B; Ghanima W; Einvik G; Aarli B; Brønstad E; Skjønsberg OH; Stavem K
    Br J Haematol; 2021 Aug; 194(3):542-546. PubMed ID: 34028814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low rates of venous thromboembolism in hospitalised COVID-19 patients: an Australian experience.
    Ong J; Walker P; Singh KP; Bishop E; Htun K
    Intern Med J; 2022 Jan; 52(1):37-41. PubMed ID: 34524710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The 2023 Belgian clinical guidance on anticoagulation management in hospitalized and ambulatory COVID-19 patients.
    Vanassche T; Engelen MM; Orlando C; Vandenbosch K; Gadisseur A; Hermans C; Jochmans K; Minon JM; Motte S; Peperstraete H; Péters P; Sprynger M; Lancellotti P; Dehaene I; Emonts P; Vandenbriele C; Verhamme P; Oury C
    Acta Clin Belg; 2023 Dec; 78(6):497-508. PubMed ID: 37548503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Deep venous thrombosis incidence in patients with COVID-19 acute respiratory distress syndrome, under intermediate dose of chemical thromboprophylaxis].
    Hunter M; Lurbet MF; Parodi J; Mandó F; Bonelli I; Rodríguez PO; López Saubidet I
    Medicina (B Aires); 2022; 82(2):181-184. PubMed ID: 35417380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of High-Dose Prophylactic Anticoagulation in Critically Ill Patients With COVID-19 Pneumonia.
    Tacquard C; Mansour A; Godon A; Godet J; Poissy J; Garrigue D; Kipnis E; Rym Hamada S; Mertes PM; Steib A; Ulliel-Roche M; Bouhemad B; Nguyen M; Reizine F; Gouin-Thibault I; Besse MC; Collercandy N; Mankikian S; Levy JH; Gruel Y; Albaladejo P; Susen S; Godier A;
    Chest; 2021 Jun; 159(6):2417-2427. PubMed ID: 33465342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and mortality due to thromboembolic events during the COVID-19 pandemic: Multi-sourced population-based health records cohort study.
    Aktaa S; Wu J; Nadarajah R; Rashid M; de Belder M; Deanfield J; Mamas MA; Gale CP
    Thromb Res; 2021 Jun; 202():17-23. PubMed ID: 33711754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors Associated With Risk of Postdischarge Thrombosis in Patients With COVID-19.
    Li P; Zhao W; Kaatz S; Latack K; Schultz L; Poisson L
    JAMA Netw Open; 2021 Nov; 4(11):e2135397. PubMed ID: 34807256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thromboembolic Disease in Patients With Cancer and COVID-19: Risk Factors, Prevention and Practical Thromboprophylaxis Recommendations-State-of-the-Art.
    Dimakakos E; Gomatou G; Catalano M; Olinic DM; Spyropoulos AC; Falanga A; Maraveyas A; Liew A; Schulman S; Belch J; Gerotziafas G; Marschang P; Cosmi B; Spaak J; Syrigos K;
    Anticancer Res; 2022 Jul; 42(7):3261-3274. PubMed ID: 35790272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Incidence of Venous Thromboembolism in Critically Ill Patients with SARS-CoV-2 Infection Compared with Critically Ill Influenza and Community-Acquired Pneumonia Patients: A Retrospective Chart Review.
    Boyd S; Sheng Loh K; Lynch J; Alrashed D; Muzzammil S; Marsh H; Masoud M; Bin Ihsan S; Martin-Loeches I
    Med Sci (Basel); 2022 Jun; 10(2):. PubMed ID: 35736350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit: The INSPIRATION Randomized Clinical Trial.
    ; Sadeghipour P; Talasaz AH; Rashidi F; Sharif-Kashani B; Beigmohammadi MT; Farrokhpour M; Sezavar SH; Payandemehr P; Dabbagh A; Moghadam KG; Jamalkhani S; Khalili H; Yadollahzadeh M; Riahi T; Rezaeifar P; Tahamtan O; Matin S; Abedini A; Lookzadeh S; Rahmani H; Zoghi E; Mohammadi K; Sadeghipour P; Abri H; Tabrizi S; Mousavian SM; Shahmirzaei S; Bakhshandeh H; Amin A; Rafiee F; Baghizadeh E; Mohebbi B; Parhizgar SE; Aliannejad R; Eslami V; Kashefizadeh A; Kakavand H; Hosseini SH; Shafaghi S; Ghazi SF; Najafi A; Jimenez D; Gupta A; Madhavan MV; Sethi SS; Parikh SA; Monreal M; Hadavand N; Hajighasemi A; Maleki M; Sadeghian S; Piazza G; Kirtane AJ; Van Tassell BW; Dobesh PP; Stone GW; Lip GYH; Krumholz HM; Goldhaber SZ; Bikdeli B
    JAMA; 2021 Apr; 325(16):1620-1630. PubMed ID: 33734299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Impact of COVID-19 on Vascular Surgery Practice: A Systematic Review.
    Ulloa JH; Figueroa V; Cifuentes JS; Pinto P; Lurie F
    Vasc Endovascular Surg; 2021 Aug; 55(6):601-611. PubMed ID: 33657926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Venous and arterial thrombosis in COVID-19: An updated narrative review.
    Duhailib ZA; Oczkowski S; Polok K; Fronczek J; Szczeklik W; Piticaru J; Mammen MJ; Alshamsi F; Eikelboom J; Belley-Cote E; Alhazzani W
    J Infect Public Health; 2022 Jun; 15(6):689-702. PubMed ID: 35643053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.